77 related articles for article (PubMed ID: 18843999)
1. [Cost-effectiveness analysis on compound anti-hypertensive tablets for primary hypertension].
Wu YQ; Hu YH; Ren T; Wu T; Tao QS; Qin XY; Zhang Y; Zhan SY; Cao WH; Li LM
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Apr; 29(4):383-6. PubMed ID: 18843999
[TBL] [Abstract][Full Text] [Related]
2. How willing are the public to pay for anti-hypertensive drugs for primary prevention of cardiovascular disease: a survey in a Chinese city.
Tang JL; Wang WZ; An JG; Hu YH; Cheng SH; Griffiths S
Int J Epidemiol; 2010 Feb; 39(1):244-54. PubMed ID: 19491141
[TBL] [Abstract][Full Text] [Related]
3. Cost implications of development of diabetes in the ALPINE study.
Lindholm LH; Kartman B; Carlberg B; Persson M; Svensson A; Samuelsson O
J Hypertens Suppl; 2006 Mar; 24(1):S65-72. PubMed ID: 16601576
[TBL] [Abstract][Full Text] [Related]
4. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
[TBL] [Abstract][Full Text] [Related]
6. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
7. [Study on the long-term efficacy and safety of medicine named 'Beijing Hypertensive No. 0' in patients with primary hypertension].
Zhang Y; Hu YH; Cao WH; Qin XY; Ren T; Tao QS; Wu T; Wu YQ; Zhan SY; Li LM
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Mar; 29(3):286-9. PubMed ID: 18788531
[TBL] [Abstract][Full Text] [Related]
8. Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
Linjer E; Hedner T; Jönsson B; Ekbom T; Lindholm LH; Dahlöf B; de Faire U; Scherstén B;
Blood Press; 2005; 14(2):107-13. PubMed ID: 16036488
[TBL] [Abstract][Full Text] [Related]
9. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
Saito I; Saruta T;
Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension.
Doyle J; Omvik P; Arikian S; Casciano J; Casciano R; Gonzalez MA; Arocho R
Manag Care Interface; 2001 Mar; 14(3):82-7. PubMed ID: 11301961
[TBL] [Abstract][Full Text] [Related]
12. Renoprotective effect and cost-effectiveness of using benidipine, a calcium channel blocker, to lower the dose of angiotensin receptor blocker in hypertensive patients with albuminuria.
Saito F; Fujita H; Takahashi A; Ichiyama I; Harasawa S; Oiwa K; Takahashi N; Otsuka Y; Uchiyama T; Kanmatsuse K; Kushiro T
Hypertens Res; 2007 Jan; 30(1):39-47. PubMed ID: 17460370
[TBL] [Abstract][Full Text] [Related]
13. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
Fender P; Guilhot J; Tilly B; Salanave B; Allemand H
Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
[TBL] [Abstract][Full Text] [Related]
15. Cost-benefit of treating hypertension.
Jönsson BG
J Hypertens Suppl; 1994 Dec; 12(10):S65-70. PubMed ID: 7769494
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention for Endpoint reduction in hypertension (LIFE) study.
McInnes G; Burke TA; Carides G
J Hum Hypertens; 2006 Jan; 20(1):51-8. PubMed ID: 16357874
[TBL] [Abstract][Full Text] [Related]
17. Cost of switching hypertensive patients from enalapril maleate to lisinopril.
Lindgren-Furmaga EM; Schuna AA; Wolff NL; Goodfriend TL
Am J Hosp Pharm; 1991 Feb; 48(2):276-9. PubMed ID: 1848392
[TBL] [Abstract][Full Text] [Related]
18. Cost-benefit aspects of treatment of hypertension in the elderly.
Lindholm LH; Johannesson M
Blood Press Suppl; 1995; 3():11-4. PubMed ID: 8535536
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis: controlled-release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-Combi) study.
Saito I; Fujikawa K; Saruta T;
Hypertens Res; 2008 Jul; 31(7):1399-405. PubMed ID: 18957811
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
Coleman CI; McKay RG; Boden WE; Mather JF; White CM
Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
